Related Experiment Video
Updated: Jun 18, 2026

07:59
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
Published on: March 4, 2017
Integrative Oncology Models of Care: Practice Patterns From NCCN Member Institutions
Angela F Bazzell1, Lydia T Madsen1, Lindsey Bandini2
1From Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, Texas.
Journal of the Advanced Practitioner in Oncology
|February 16, 2026
Summary
Cancer patients seek integrative oncology (IO) but face access challenges. A survey of National Comprehensive Cancer Network (NCCN) centers revealed widespread IO service offerings but significant variation in delivery and funding.
Area of Science:
- Integrative oncology
- Cancer care delivery
- Health services research
Background:
- Patients with cancer often want to use integrative oncology (IO) practices.
- Patients struggle to find safe and effective IO services and providers.
- The National Comprehensive Cancer Network (NCCN) investigated IO practices at its member institutions.
Purpose of the Study:
- To survey National Comprehensive Cancer Network (NCCN) Member Institutions on their integrative oncology (IO) practices.
- To understand how cancer centers deliver IO services to patients.
- To identify variations and potential best practices in IO service provision.
Main Methods:
- A web-based survey was distributed to representatives at NCCN Member Institutions.
- Descriptive statistics were used to compile the survey results.
- The survey focused on the types of IO services offered and methods of patient access.
Main Results:
- All 29 surveyed NCCN centers offer IO services, including nutrition, stress management, mind-body practices, physical therapy, acupuncture, and massage.
- Patient access primarily occurs through provider referral, with some self-scheduling options.
- Significant variations exist in IO service funding models (self-pay, insurance, philanthropy) and referral algorithms.
Conclusions:
- There is considerable variation in how NCCN Member Institutions deliver integrative oncology (IO) services.
- Findings offer guidance for healthcare organizations developing IO services and highlight areas for aligning best practices.
- While challenging for non-academic settings, the data inform cancer providers about commonly sought IO services by patients.
Related Concept Videos
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

